Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Implementation of an Opioid Overdose and Naloxone Distribution Training in a Pharmacist Laboratory Course.

Kwon M, Moody AE, Thigpen J, Gauld A.

Am J Pharm Educ. 2020 Feb;84(2):7179. doi: 10.5688/ajpe7179.

2.

The Impact of Sociosexualization and Sexual Identity Development on the Sexual Well-Being of Youth Formerly in the Foster Care System.

Brandon-Friedman RA, Wahler EA, Pierce BJ, Thigpen JW, Fortenberry JD.

J Adolesc Health. 2020 Apr;66(4):439-446. doi: 10.1016/j.jadohealth.2019.10.025. Epub 2020 Jan 19.

PMID:
31964609
3.

Predictors of cognitive function in pediatric brain tumor patients: pre-surgery through 24-month follow-up.

Fraley CE, Thigpen JC, Pearson MM, Kuttesch JF Jr, Desjardins L, Hoskinson KR, Alvarado-Gonzalez A, Esbenshade AJ, Pastakia D, Friedman DL, Wellons JC, McNally CM, Siciliano RE, Compas BE.

Appl Neuropsychol Child. 2019 Dec 30:1-8. doi: 10.1080/21622965.2019.1706179. [Epub ahead of print]

PMID:
31887256
4.

Coverage of pharmacogenetic tests by private health insurance companies.

Park SK, Thigpen J, Lee IJ.

J Am Pharm Assoc (2003). 2019 Dec 13. pii: S1544-3191(19)30452-2. doi: 10.1016/j.japh.2019.10.003. [Epub ahead of print]

PMID:
31843376
5.

Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children.

Thigpen JC, Odle BL, Harirforoosh S.

Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):591-609. doi: 10.1007/s13318-019-00552-0. Review.

PMID:
31006834
6.

Parent reports of children's working memory, coping, and emotional/behavioral adjustment in pediatric brain tumor patients: A pilot study.

Desjardins L, Thigpen JC, Kobritz M, Bettis AH, Gruhn MA, Ichinose M, Hoskinson K, Fraley C, Vreeland A, McNally C, Compas BE.

Child Neuropsychol. 2018 Oct;24(7):959-974. doi: 10.1080/09297049.2017.1365828. Epub 2017 Oct 2.

7.

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).

Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF, Burger RA, Thigpen JT, Birrer MJ, Waggoner SE, Moore DH, Look KY, Koh WJ, Monk BJ.

Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27.

8.

Coping, emotion regulation, and psychopathology in childhood and adolescence: A meta-analysis and narrative review.

Compas BE, Jaser SS, Bettis AH, Watson KH, Gruhn MA, Dunbar JP, Williams E, Thigpen JC.

Psychol Bull. 2017 Sep;143(9):939-991. doi: 10.1037/bul0000110. Epub 2017 Jun 15. Review.

PMID:
28616996
9.

Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere.

Stern HP, Lipman J, Andersen SL, Bossaer JB, Thigpen J.

Clin Pediatr (Phila). 2017 Aug;56(9):805-810. doi: 10.1177/0009922817706148. Epub 2017 May 1. Review. No abstract available.

PMID:
28459152
10.

Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.

Ko D, Thigpen JL, Otis JA, Forster K, Henault L, Quinn E, Tripodis Y, Berger PB, Limdi N, Hylek EM.

Int J Cardiol. 2017 Jan 15;227:808-812. doi: 10.1016/j.ijcard.2016.10.055. Epub 2016 Oct 24.

11.

Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.

Mai PL, Piedmonte M, Han PK, Moser RP, Walker JL, Rodriguez G, Boggess J, Rutherford TJ, Zivanovic O, Cohn DE, Thigpen JT, Wenham RM, Friedlander ML, Hamilton CA, Bakkum-Gamez J, Olawaiye AB, Hensley ML, Greene MH, Huang HQ, Wenzel L.

Gynecol Oncol. 2017 Apr;145(1):122-129. doi: 10.1016/j.ygyno.2017.02.008. Epub 2017 Feb 10.

12.

Stability of sildenafil in combination with heparin and dopamine.

Luu Y, Thigpen J, Brown SD.

Am J Health Syst Pharm. 2017 Jan 1;74(1):e64-e71. doi: 10.2146/ajhp150853. Epub 2016 Dec 22.

PMID:
28007723
13.

Presurgical assessment of cognitive function in pediatric brain tumor patients: feasibility and initial findings.

Thigpen JC, Pearson M, Robinson KE, Andreotti C, Dunbar JP, Watson KH, Dejardins L, Holmes L, Byram R, Fraley C, Compas BE.

Neurooncol Pract. 2016 Dec;3(4):261-267. Epub 2016 Jan 24.

14.

Parental Depressive Symptoms and Youth Internalizing and Externalizing Problems: The Moderating Role of Interparental Conflict.

Breslend NL, Parent J, Forehand R, Compas BE, Thigpen JC, Hardcastle E.

J Fam Violence. 2016 Oct;31(7):823-831. Epub 2016 May 19.

15.

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.

Moore KN, Java JJ, Slaughter KN, Rose PG, Lanciano R, DiSilvestro PA, Thigpen JT, Lee YC, Tewari KS, Chino J, Seward SM, Miller DS, Salani R, Moore DH, Stehman FB.

Gynecol Oncol. 2016 Nov;143(2):294-301. doi: 10.1016/j.ygyno.2016.08.317. Epub 2016 Aug 17.

16.

AdvoCaring: A Cocurricular Program to Provide Advocacy and Caring to Underserved Populations in Baltimore.

Fritsch MA, Culver N, Culhane N, Thigpen J, Lin A.

Am J Pharm Educ. 2016 Sep 25;80(7):126.

17.

Paroxysmal atrial fibrillation and the hazards of under-treatment.

Aronis KN, Thigpen JL, Tripodis Y, Dillon C, Forster K, Henault L, Quinn EK, Berger PB, Limdi NA, Hylek EM.

Int J Cardiol. 2016 Jan 1;202:214-20. doi: 10.1016/j.ijcard.2015.09.006. Epub 2015 Sep 11.

18.

A Subgroup Analysis of the Impact of Self-testing Frequency on Examination Scores in a Pathophysiology Course.

Panus PC, Stewart DW, Hagemeier NE, Thigpen JC, Brooks L.

Am J Pharm Educ. 2014 Nov 15;78(9):165. doi: 10.5688/ajpe789165.

19.

Race influences warfarin dose changes associated with genetic factors.

Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, Hill CE, Arnett DK, Beasley TM.

Blood. 2015 Jul 23;126(4):539-45. doi: 10.1182/blood-2015-02-627042. Epub 2015 May 29.

20.

Efficacy and moderators of a family group cognitive-behavioral preventive intervention for children of parents with depression.

Compas BE, Forehand R, Thigpen J, Hardcastle E, Garai E, McKee L, Keller G, Dunbar JP, Watson KH, Rakow A, Bettis A, Reising M, Cole D, Sterba S.

J Consult Clin Psychol. 2015 Jun;83(3):541-53. doi: 10.1037/a0039053.

21.

Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.

Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, Hylek EM, Limdi NA.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):8-14. doi: 10.1161/CIRCOUTCOMES.113.000371. Epub 2015 Jan 13.

22.

Neonatal abstinence syndrome: a challenge for medical providers, mothers, and society.

Thigpen J, Melton ST.

J Pediatr Pharmacol Ther. 2014 Jul;19(3):144-6. doi: 10.5863/1551-6776-19.3.144. No abstract available.

24.

Observed parental responsiveness/warmth and children's coping: cross-sectional and prospective relations in a family depression preventive intervention.

Watson KH, Dunbar JP, Thigpen J, Reising MM, Hudson K, McKee L, Forehand R, Compas BE.

J Fam Psychol. 2014 Jun;28(3):278-86. doi: 10.1037/a0036672. Epub 2014 Apr 28.

25.

Pharmacy student self-testing as a predictor of examination performance.

Stewart D, Panus P, Hagemeier N, Thigpen J, Brooks L.

Am J Pharm Educ. 2014 Mar 12;78(2):32. doi: 10.5688/ajpe78232.

26.

Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper.

Herzog TJ, Armstrong DK, Brady MF, Coleman RL, Einstein MH, Monk BJ, Mannel RS, Thigpen JT, Umpierre SA, Villella JA, Alvarez RD.

Gynecol Oncol. 2014 Jan;132(1):8-17. doi: 10.1016/j.ygyno.2013.11.008. Epub 2013 Nov 15.

27.

Stability of extemporaneously prepared lansoprazole suspension at two temperatures.

Morrison JT, Lugo RA, Thigpen JC, Brown SD.

J Pediatr Pharmacol Ther. 2013 Apr;18(2):122-7. doi: 10.5863/1551-6776-18.2.122.

28.

Reversal of oral anticoagulation.

Thigpen JL, Limdi NA.

Pharmacotherapy. 2013 Nov;33(11):1199-213. doi: 10.1002/phar.1270. Epub 2013 Apr 18. Review.

29.

The estrogenic content of rodent diets, bedding, cages, and water bottles and its effect on bisphenol A studies.

Thigpen JE, Setchell KD, Kissling GE, Locklear J, Caviness GF, Whiteside T, Belcher SM, Brown NM, Collins BJ, Lih FB, Tomer KB, Padilla-Banks E, Camacho L, Adsit FG, Grant M.

J Am Assoc Lab Anim Sci. 2013 Mar;52(2):130-41. Review.

30.

Cytokine use and survival in the first-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

Stehman FB, Brady MF, Thigpen JT, Rossi EC, Burger RA.

Gynecol Oncol. 2012 Dec;127(3):495-501. doi: 10.1016/j.ygyno.2012.09.002. Epub 2012 Sep 19.

31.

The role of parent depressive symptoms in positive and negative parenting in a preventive intervention.

Forehand R, Thigpen JC, Parent J, Hardcastle EJ, Bettis A, Compas BE.

J Fam Psychol. 2012 Aug;26(4):532-41. doi: 10.1037/a0028406. Epub 2012 May 21.

32.

Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study.

Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML, Monk BJ, Randall ME.

Gynecol Oncol. 2012 Apr;125(1):87-93. doi: 10.1016/j.ygyno.2011.12.414. Epub 2011 Dec 8.

PMID:
22155678
33.

Cognitive reappraisal and secondary control coping: associations with working memory, positive and negative affect, and symptoms of anxiety/depression.

Andreotti C, Thigpen JE, Dunn MJ, Watson K, Potts J, Reising MM, Robinson KE, Rodriguez EM, Roubinov D, Luecken L, Compas BE.

Anxiety Stress Coping. 2013;26(1):20-35. doi: 10.1080/10615806.2011.631526. Epub 2011 Nov 17.

PMID:
22091879
34.

Family group cognitive-behavioral preventive intervention for families of depressed parents: 18- and 24-month outcomes.

Compas BE, Forehand R, Thigpen JC, Keller G, Hardcastle EJ, Cole DA, Potts J, Watson KH, Rakow A, Colletti C, Reeslund K, Fear J, Garai E, McKee L, Merchant MJ, Roberts L.

J Consult Clin Psychol. 2011 Aug;79(4):488-99. doi: 10.1037/a0024254.

35.

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.

Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA.

Gynecol Oncol. 2011 May 1;121(2):303-8. doi: 10.1016/j.ygyno.2011.01.030. Epub 2011 Feb 16.

36.

Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.

Moore KN, Tian C, McMeekin DS, Thigpen JT, Randall ME, Gallion HH.

Cancer. 2010 Dec 1;116(23):5407-14. doi: 10.1002/cncr.25480. Epub 2010 Aug 24.

37.

Photometric calibration for quantitative spectral microscopy under transmitted illumination.

Thigpen J, Merchant FA, Shah SK.

J Microsc. 2010 Sep 1;239(3):200-14. doi: 10.1111/j.1365-2818.2010.03366.x.

38.

Endotoxin, coliform, and dust levels in various types of rodent bedding.

Whiteside TE, Thigpen JE, Kissling GE, Grant MG, Forsythe D.

J Am Assoc Lab Anim Sci. 2010 Mar;49(2):184-9.

39.

Multispectral microscopy and cell segmentation for analysis of thyroid fine needle aspiration cytology smears.

Wu X, Thigpen J, Shah SK.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:5645-8. doi: 10.1109/IEMBS.2009.5333764.

PMID:
19964406
40.

Open- and closed-formula laboratory animal diets and their importance to research.

Barnard DE, Lewis SM, Teter BB, Thigpen JE.

J Am Assoc Lab Anim Sci. 2009 Nov;48(6):709-13.

41.

Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer: a Gynecologic Oncology Group Study.

Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Risinger JI, Thigpen JT, Fleming GF, Gallion HH, Maxwell GL.

Cancer. 2010 Jan 15;116(2):355-61. doi: 10.1002/cncr.24769.

42.

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.

Fleming GF, Sill MW, Darcy KM, McMeekin DS, Thigpen JT, Adler LM, Berek JS, Chapman JA, DiSilvestro PA, Horowitz IR, Fiorica JV.

Gynecol Oncol. 2010 Jan;116(1):15-20. doi: 10.1016/j.ygyno.2009.09.025. Epub 2009 Oct 18.

43.

Early sexual behavior in a sample of low-income, African American Children.

Thigpen JW.

J Sex Res. 2009 Jan-Feb;46(1):67-79. doi: 10.1080/00224490802645286.

PMID:
19116864
44.

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM.

J Clin Oncol. 2009 Jan 1;27(1):127-45. doi: 10.1200/JCO.2008.17.2627. Epub 2008 Nov 17.

PMID:
19018081
45.

Variations in phytoestrogen content between different mill dates of the same diet produces significant differences in the time of vaginal opening in CD-1 mice and F344 rats but not in CD Sprague-Dawley rats.

Thigpen JE, Setchell KD, Padilla-Banks E, Haseman JK, Saunders HE, Caviness GF, Kissling GE, Grant MG, Forsythe DB.

Environ Health Perspect. 2007 Dec;115(12):1717-26.

46.

Peripheral intravenous extravasation: nursing procedure for initial treatment.

Thigpen JL.

Neonatal Netw. 2007 Nov-Dec;26(6):379-84. Review.

PMID:
18069429
47.

Clinical trial endpoints in ovarian cancer: report of an FDA/ASCO/AACR Public Workshop.

Bast RC, Thigpen JT, Arbuck SG, Basen-Engquist K, Burke LB, Freedman R, Horning SJ, Ozols R, Rustin GJ, Spriggs D, Wenzel LB, Pazdur R.

Gynecol Oncol. 2007 Nov;107(2):173-6.

PMID:
17950384
48.

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.

McMeekin DS, Filiaci VL, Thigpen JT, Gallion HH, Fleming GF, Rodgers WH; Gynecologic Oncology Group study.

Gynecol Oncol. 2007 Jul;106(1):16-22.

PMID:
17574073
49.

Clinical trials in gynecological cancer.

Trimble EL, Davis J, Disaia P, Fujiwara K, Gaffney D, Kristensen G, Ledermann J, Pfisterer J, Quinn M, Reed N, Schoenfeldt M, Thigpen JT; Gynecologic Cancer Intergroup.

Int J Gynecol Cancer. 2007 May-Jun;17(3):547-56. Review.

PMID:
17504371
50.

Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.

Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S; Gynecologic Oncology Group.

J Clin Oncol. 2007 Jul 1;25(19):2804-10. Epub 2007 May 14.

PMID:
17502627

Supplemental Content

Loading ...
Support Center